case_images: PMC10516292_01
case_images: Implanted AFR device (Occlutech, Germany) before disconnecting. AFR device (Occlutech, Germany) right before deployment, RA, right atrium; LA, left atrium.
case_images: fcvm-10-1197985-g002.jpg
case_images: PMC10516292_01_fcvm-10-1197985-g002.jpg
case_images: F2
case_images: AFR device could be deployed (Figure 2). After confirming the correct position and checking the oxygen saturation level of greater than 85% and stable hemodynamic parameters, the device was completely and successfully released.
case_images: AFR device (Occlutech, Germany) in echocardiography. AFR device (Occlutech, Germany) with L-R shunt at rest; RA, right atrium; LA, left atrium; LV, left ventricle; RV, right ventricle.
case_images: fcvm-10-1197985-g003.jpg
case_images: PMC10516292_01_fcvm-10-1197985-g003.jpg
case_images: F3
case_images: The postinterventional echocardiography confirmed a right-to-left colour flow through the 8 mm atrial communication (Figure 3).
case_images: Echocardiography before and 6 years after implantation. (A) Before implantation: RV with septal flattening before AFR implantation. The RV/LV diameter ratio is 1: 0.87. (B) 6 years after AFR implantation. RV with decrease of the RV volume and improved LV filling. The RV/LV ratio is 0.87/1.
case_images: fcvm-10-1197985-g004.jpg
case_images: PMC10516292_01_fcvm-10-1197985-g004.jpg
case_images: F4
case_images: The cardiac catheterisation 3 years after AFR device implantation showed significant improvement (Table 1). 6 years after device implantation, her baseline saturation remained normal (98%, NHYA functional class II), the right ventricular volume and size decreased (Figure 4), NT-pro-BNP values were satisfying (Table 2) and the 6-minute walking distance was around 540 m.